Genmab — November 2018
-
Som jeg plejer at sige....det bliver bedre i morgen..;-)
-
Spil om hvad?
-
Genmab eller markedet generelt?
-
Hvad er din teori da..lad os høre?
-
Induction Therapy With Bortezomib-melphalan and Prednisone (VMP) Followed by Lenalidomide and Dexamethasone (Rd) Versus Carfilzomib, Lenalidomide and Dexamethasone (KRd) Plus/Minus Daratumumab, 18 Cycles, Followed by Consolidation and Maintenance Therapy With Lenalidomide and Daratumumab: Phase III, Multicenter, Randomized Trial for Elderly Fit Newly Diagnosed Multiple Myeloma Patients Aged Between 65 and 80 Years
-
Forelskelse plejer da normalt at være postivt??
-
Og hvis de vil byde op til dans m
å de vel betale kassen? -
Jeg har lyttet lidt til JvdW præsentation hos Jefferies i dag. Desværre dør lyden efter godt 11 minutter. Måske det virker bedre i morgen:-) MEN han nævner Hexabody: Discussing access to HexaBody with other partners/Pharma and Biotech partners as we speak. HexElect: A lot of interest/attention from pharma companies. Og vedr. DARA patentudløb: Nuværende løber til slutningen af 2020'erne men med SC forlænges patendet til midten af 2030'erne og med uændret royalty til Genmab. Og så døde lyden..
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
